Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies,” published in the February 2025 issue of American Journal of Hematology by Senapati et ...
February 14, 2025 – IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, yesterday presented Phase 1 data on its allogeneic gamma ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...
Detailed price information for Bio-Path Holdings (BPTH-Q) from The Globe and Mail including charting and trades.
IN8bio has announced encouraging new clinical data from its ongoing Phase I trial of INB-100, an allogeneic gamma-delta T ...
Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...
The Standard-Times on MSN2d
New Bedford family of toddler fighting leukemia gets support from Cops for Kids with CancerCops for Kids with Cancer seeks to remove the financial burden for families impacted by a cancer diagnosis. This week they ...
Worcester Telegram on MSN9h
'Fight like a kid': Local basketball teams rally together to support kids battling diseasesFor the past month, local basketball programs have teamed up to raise awareness and spread hope for 9-year-old Autumn and ...
Brice and Amanda Dieter of Jamestown had their figurative worlds upended in October 2023. It was at this time that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback